Latest data from May 6, 2022
Number of Health Center respondents = 21 (72% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
Metrics | Value |
---|---|
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 | 1,635 |
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) | 24.80% |
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 | 119 |
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) | 18.18% |
Patients by Race and Ethnicity
Race/Ethnicity | Patients Tested, Virus Detection (PCR, Antigen)2 | Patients Tested Positive, Virus Detection (PCR, Antigen)2 |
---|---|---|
White, Non-Hispanic/Latino Patients | 70.28% | 60.50% |
White, Hispanic/Latino Patients | 4.95% | 2.52% |
Black/African American, Non-Hispanic/Latino Patients | 11.07% | 9.24% |
Black/African American, Hispanic/Latino Patients | 0.06% | 0.00% |
Asian Patients3 | 0.55% | 0.00% |
American Indian/Alaska Native Patients3 | 0.12% | 0.00% |
Native Hawaiian/Other Pacific Islander Patients3 | 0.43% | 0.00% |
Patients with More Than One Race3 | 0.92% | 0.84% |
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 5.08% | 0.84% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 4.95% | 25.21% |
Unreported/Refused to Report Race and Ethnicity | 1.59% | 0.84% |
Patients Vaccinated
Metrics | Value |
---|---|
COVID-19 Immunization Series Initiated | 100 |
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 56.16% |
COVID-19 Immunization Series Completed | 115 |
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 45.35% |
COVID-19 Immunization Series Additional | 677 |
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 36.12% |
Vaccinations by Race and Ethnicity
Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
---|---|---|---|
White, Non-Hispanic/Latino Patients | 32.00% | 40.87% | 59.82% |
White, Hispanic/Latino Patients | 16.00% | 7.83% | 5.61% |
Black/African American, Non-Hispanic/Latino Patients | 22.00% | 17.39% | 16.99% |
Black/African American, Hispanic/Latino Patients | 0.00% | 0.00% | 0.00% |
Asian Patients3 | 0.00% | 0.00% | 0.89% |
American Indian/Alaska Native Patients3 | 0.00% | 0.00% | 8.71% |
Native Hawaiian/Other Pacific Islander Patients3 | 0.00% | 1.74% | 0.00% |
Patients with More Than One Race3 | 3.00% | 2.61% | 0.44% |
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 0.00% | 4.35% | 1.18% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 0.00% | 21.74% | 4.73% |
Unreported/Refused to Report Race and Ethnicity | 27.00% | 3.48% | 1.62% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)
Metrics | Value |
---|---|
Less Than 1 Hour | 47.62% |
1 to 24 Hours | 38.10% |
More Than 24 Hours | 14.29% |
N/A | 0.00% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
Metrics | Value |
---|---|
Financial reimbursement for costs associated with vaccine administration | 4.76% |
Staffing to administer the vaccine | 9.52% |
Vaccine confidence | 33.33% |
Vaccine storage capacity | 4.76% |
Vaccine supply | 4.76% |
Other | 0.00% |
None | 57.14% |
Operations and Staff
Metrics | Value |
---|---|
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 9.52% |
Average Percent of Health Center Visits Conducted Virtually | 9.29% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
Metrics | Value |
---|---|
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 14.29% |
Number of Mobile Van Sites | 6 |
Number of Pop-up Clinics | 10 |
Number of School-Based Vaccination Sites | 0 |
Number of Family Vaccination Clinics | 1 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
Metrics | Value |
---|---|
Direct provision of monoclonal antibody therapies | 4.76% |
Refer patients to another organization that provides monoclonal antibody therapies | 47.62% |
None | 47.62% |
Challenges in Providing Access to Monoclonal Antibody Therapy
Metrics | Value |
---|---|
Access to therapeutics | 14.29% |
Patient awareness/education | 14.29% |
Staffing capacity | 14.29% |
Therapy administration/onsite logistics | 14.29% |
Other | 9.52% |
None | 52.38% |
Test Kit Distribution
Metrics | Value |
---|---|
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program | 9 |
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program | 1,798 |
Test Kit Distribution Methods4
Metrics | Value |
---|---|
Provided to Existing Health Center Patients | 66.67% |
Provided to General Public Who Came to the Health Center | 33.33% |
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 11.11% |
Provided at Other Community Events | 22.22% |
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 11.11% |
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 0.00% |
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 0.00% |
Provided to school-age children and/or their families directly or through partnerships with schools | 0.00% |
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 22.22% |
Other | 0.00% |
N95 Mask Distribution
Metrics | Value |
---|---|
Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program | 8 |
Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program | 2,164 |
N95 Mask Distribution Methods5
Metrics | Value |
---|---|
Provided to Existing Health Center Patients | 75.00% |
Provided to General Public Who Came to the Health Center | 25.00% |
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 12.50% |
Provided at Other Community Events | 12.50% |
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 12.50% |
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 0.00% |
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 0.00% |
Provided to school-age children and/or their families directly or through partnerships with schools | 0.00% |
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 12.50% |
Other | 0.00% |
Oral Antiviral Medication Distribution
Metrics | Value |
---|---|
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program | 2 |
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication | 0.00% |
Oral Antiviral Medication Distribution by Race and Ethnicity
Race/Ethnicity | Value |
---|---|
White, Non-Hispanic/Latino Patients | 100.00% |
White, Hispanic/Latino Patients | 0.00% |
Black/African American, Non-Hispanic/Latino Patients | 0.00% |
Black/African American, Hispanic/Latino Patients | 0.00% |
Asian Patients3 | 0.00% |
American Indian/Alaska Native Patients3 | 0.00% |
Native Hawaiian/Other Pacific Islander Patients3 | 0.00% |
Patients with More Than One Race3 | 0.00% |
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 0.00% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 0.00% |
Unreported/Refused to Report Race and Ethnicity | 0.00% |
Oral Antiviral Medication Distribution by Population Type
Metrics | Value |
---|---|
Migratory/Agricultural Workers | 0.00% |
Patients Experiencing Homelessness | 0.00% |
Patients Who Are Residents of Public Housing | 0.00% |
Patients with Limited English Proficiency | 0.00% |
Children Under 18 Years of Age | 0.00% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.
5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.